Back to News
Private Equity

Middle Market Digest: Morningside, Waud Capital and More

|
Published: February 24th, 2020
Middle market growth equity and venture capital investments of $500 million or less between Feb. 13 and Feb. 20.

Hello and welcome to Middle Market Digest, a compilation of news and notes on deals worth $500 million or less from private equity, growth equity and venture capital practitioners.

This week’s edition covers deals from Feb. 13 to Feb. 20. Below the lead item, deals are listed in alphabetical order by target name.

  • Agriculture production software maker SemiosBio Technologies Inc. said on Tuesday, Feb. 18, it raised $75 million in private equity funding led by Boston-based Morningside Group. The deal brings the total funding for Vancouver, British Columbia-based Semios to $115 million since the firm was founded in 2010. Semios compiles real-time, acre-by-acre sensory data on orchards to improve sustainability and profitability of harvest. Mick Sawka, investment manager at Morningside Group, worked on the deal, along with  Michael Gilbert, CEO and founder of Semios. Raymond James & Associates Inc. advised Semios on the deal, with Fort Capital working on financing. Hong Kong-based Morningside Group is currently investing out of its $1 billion Evolution Fund I LP, which closed in 2018. The firm does not disclose investment criteria. Deal Memo
  • Waud Capital LLC-backed Ivy Rehab Physical Therapy said on Thursday, Feb. 13, it paid an undisclosed sum for Whiting, N.J.-based All-Care Physical Therapy, which operates in 13 locations in the Garden State. White Plains, N.Y.-based Ivy Rehab Physical Therapy said its footprint now comprises 220 facilities. Jeremy VanDevender, Ivy’s chief development officer, worked on the deal, along with Michael Yorke, president and founder of All-Care Physical Therapy. Chicago-based Waud Capital typically invests between $50 million and $200 million in healthcare services, technology and business services. Deal Memo

Editor’s note: The original version of this article, including advisers and other details, was published earlier on The Deal’s premium subscription website. For access, log in to TheDeal.com or use the form below to request a free trial.

Middle Market Awards: The Deal released the shortlist for our 2020 Middle Market Awards. Take a look at the list and check if your firm was among those shortlisted, we hope to see everyone at our awards ceremony in April. Don’t forget to reserve your seat.

This Content is Only for The Deal Subscribers

The Deal provides actionable, intraday coverage of mergers, acquisitions and all other changes in corporate control to institutional investors, private equity, hedge funds and the firms that serve them.

If you’re already a subscriber, log in to view this article here.

More From Private Equity

Mergers & Acquisitions

Checkmarx Sale Reflects Demand for Application Security Testing

By Chris Nolter
|
Published: March 20th, 2020
Along with Hellman &Friedman, companies such Synopsys, Japan’s NTT and Microsoft's GitHub have acquired application security testing companies as trends in cyber attacks and regulation.
Private Equity

Tri-Point to Liquidate After Bidder Walks Away

By David Elman
|
Published: March 19th, 2020
The First Reserve-backed oilfield services company files for Chapter 11 to wind down after market conditions lead a bidder to cease due diligence.
Mergers & Acquisitions

Coronavirus Clouds M&A Lending Market

By Steve Gelsi
|
Published: March 12th, 2020
Lenders continue to process loans but concerns about the impact of the spread of Covid-19 is stoking more uncertainty as financial markets signal a potential recession.